IFP Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,765
| Closed | -$141K | – | 5064 |
|
|
2025
Q1 | $141K | Sell |
1,765
-27
| -2% | -$2.09K | ﹤0.01% | 1339 |
|
|
2024
Q4 | $91.5K | Buy |
1,792
+64
| +4% | +$3.15K | ﹤0.01% | 1515 |
|
|
2024
Q3 | $71.3K | Sell |
1,728
-164
| -9% | -$7.87K | ﹤0.01% | 1561 |
|
|
2024
Q2 | $91.1K | Sell |
1,892
-23
| -1% | -$1.02K | ﹤0.01% | 1412 |
|
|
2024
Q1 | $91.9K | Buy |
1,915
+10
| +0.5% | +$534 | ﹤0.01% | 1330 |
|
|
2023
Q4 | $124K | Sell |
1,905
-34
| -2% | -$2.05K | 0.01% | 1161 |
|
|
2023
Q3 | $127K | Buy |
1,939
+510
| +36% | +$32.1K | 0.01% | 1157 |
|
|
2023
Q2 | $83.1K | Buy |
1,429
+43
| +3% | +$2.71K | ﹤0.01% | 1401 |
|
|
2023
Q1 | $58.9K | Sell |
1,386
-219
| -14% | -$13.1K | ﹤0.01% | 1496 |
|
|
2022
Q4 | $73K | Buy |
1,605
+123
| +8% | +$8.92K | ﹤0.01% | 1972 |
|
|
2022
Q3 | $68K | Buy |
1,482
+24
| +2% | +$1.79K | ﹤0.01% | 2148 |
|
|
2022
Q2 | $66K | Hold |
1,458
| – | – | ﹤0.01% | 1973 |
|
|
2022
Q1 | $66K | Buy |
1,458
+234
| +19% | +$19.2K | ﹤0.01% | 1973 |
|
|
2021
Q4 | $111K | Sell |
1,224
-10
| -0.8% | -$857 | ﹤0.01% | 1227 |
|
|
2021
Q3 | $101K | Sell |
1,234
-12
| -1% | -$1.01K | ﹤0.01% | 1297 |
|
|
2021
Q2 | $113K | Sell |
1,246
-1
| -0.1% | -$97 | ﹤0.01% | 1184 |
|
|
2021
Q1 | $136K | Buy |
1,247
+201
| +19% | +$20.9K | ﹤0.01% | 1020 |
|
|
2020
Q4 | $93K | Buy |
+1,046
| New | +$73.9K | ﹤0.01% | 1172 |
|
IFP Advisors's NARI Position: Q2 2025 in Review
IFP Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2025, closing a stake of 1,765 shares — an estimated $141K sold.
IFP Advisors first reported a position in NARI in Q4 2020 and held it in 18 quarters. The position peaked at $141K in Q1 2025. 0 funds tracked by Wall St. Rank hold NARI as of Q2 2025.
- IFP Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- IFP Advisors sold 1,765 Inari Medical, Inc. Common Stock shares in Q2 2025, an estimated $141K.
- IFP Advisors first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 18 quarters.
- IFP Advisors's Inari Medical, Inc. Common Stock position peaked at $141K in Q1 2025.
- 0 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2025.
Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.